SH23192Improving preparedness for introducing and scaling up long-acting HIV pre-exposure prophylaxis in Asia
In June 2023, a roundtable of experts and stakeholders was held in Singapore focusing on the introduction of long-acting formulations of HIV pre-exposure prophylaxis in Asia, particularly long-acting injectable cabotegravir. This paper describes issues discussed at the roundtable related to preparedness in research and implementation science, product licensing and accessibility, and capacity readiness for scale-up of long-acting injectable pre-exposure prophylaxis and future pre-exposure prophylaxis products.
SH23192 Abstract | SH23192 Full Text | SH23192PDF (167 KB) Open Access Article